Autologous Muscle Fiber Fragment Injections

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWake Forest University Health Sciences

About this trial

To regenerate functional anal sphincter muscle using muscle fiber fragments that contain muscle precursor cells (MPCs)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 years of age

participants must experience 4 or more Fecal Incontinence (FI) episodes per 2 week period

participants must score >10 on Cleveland Clinic Fecal Incontinence Severity Scoring System (CCIS)

participants must have had symptoms for at least 12 months

Disqualifiers

participants with symptomatic anorectal disease including symptomatic hemorrhoid disease, anal fissure or fistula causing symptoms such as bleeding, swelling, pain, or drainage

participants with pre-existing ano-rectal pain of any cause

participants with incontinence of flatus only

chronic watery diarrhea which is the primary cause for fecal incontinence

Trial design

Design model

Single group

Treatments tested in this trial

  • Muscle Fiber Fragment (MFF) Injections

    Procedure/Surgery

    The participant will be treated with an injection of muscle fiber fragments into the external anal sphincter at 3, 6, 9 and 12 o'clock using a 21-gauge needle to a depth of 1-2 cm from the external skin using equal amounts in each quadrant.

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Muscle Fiber Fragment (MFF) injectionsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Cleveland Clinic Fecal Incontinence Severity Scoring System (CCIS) scores (also termed the Wexner score)

fecal incontinence score from 0-20; where 0 is perfect continence and 20 is complete incontinence

Time frame
Month 3
2

Cleveland Clinic Fecal Incontinence Severity Scoring System (CCIS) scores (also termed the Wexner score)

fecal incontinence score from 0-20; where 0 is perfect continence and 20 is complete incontinence

Time frame
Month 6
3

Cleveland Clinic Fecal Incontinence Severity Scoring System (CCIS) scores (also termed the Wexner score)

fecal incontinence score from 0-20; where 0 is perfect continence and 20 is complete incontinence

Time frame
Month 12

Secondary outcomes

1

Change in Fecal Incontinence Quality of Life (FI-QOL) scores

The Fecal Incontinence Quality of Life Scale is composed of a total of 29 items; these items form four scales: Lifestyle (10 items), Coping/Behavior (9 items), Depression/Self-Perception (7 items), and Embarrassment (3 items).

Time frame
baseline, Months 3 and 12
2

Anorectal Manometry (ARM) Pressure scores

Low resting pressure is defined as \<50 mmHg during the anorectal motility exam performed with high-resolution catheter (Given, Atlanta, GA). Normal resting pressures range from 50 to 100 mmHg. A flexible catheter with solid-state pressure transducers is placed in the anal canal and rectum to obtain standard pressure measurements

Time frame
baseline, Months 3 and 12
3

Internal Anal sphincter (IAS) Pressure scores

Typical resting pressure in a healthy volunteer is 40 to 60 mmHg

Time frame
baseline, Months 3 and 12
4

Rectal Anal Inhibitory Reflex (RAIR) Pressure scores

Low resting pressure is defined as \<50 mmHg during the anorectal motility exam performed with high-resolution catheter (Given, Atlanta, GA). Normal resting pressures range from 50 to 100 mmHg. A flexible catheter with solid-state pressure transducers is placed in the anal canal and rectum to obtain Rectal Anal Inhibitory Reflex (RAIR)

Time frame
baseline, Months 3 and 12

Other outcomes

1

Anorectal endoscopic ultrasound (EUS)

This standard procedure is performed with a rotating rectal probe without sedation or deep sedation

Time frame
Months 3 and 12

Sponsors and contacts

Click on the lead sponsor to view all of their trials.